Navigation Links
Failing Heart Failure Patients

Australian teaching hospitals may be putting heart failure patients at further risk through a reluctance to prescribe them life-saving cardiovascular drugs.//

A recent study, published in the latest edition of the Medical Journal of Australia, evaluated the use of cardiovascular medications in patients with and without heart failure after a myocardial infarction (MI), otherwise known as a heart attack.

“Heart failure is a common and potentially lethal complication of MI, conferring a four-to-fivefold increase in mortality,” says Professor Henry Krum, co-author of the study and head of the NHMRC Centre of Clinical Research Excellence in Therapeutics at Monash University in Melbourne.

He says cardiovascular medication reduces the risk of disease and death in affected patients, but it is not known whether evidence-based prescribing occurs in Australian teaching hospitals.

Of the 479 patients admitted for MI who participated in the study, 116 had heart failure at some point during their hospitalisation.

But the MI patients were significantly less likely to be prescribed some types of cardiovascular medication than patients without heart failure.

Prof Krum says recent analyses have confirmed that some MI patients do derive substantial benefit from proven heart failure therapies, and their use should therefore be encouraged.

However he noted that the low prescribing rates may be explained by concerns over low blood pressure and greater clinical instability in patients with heart failure.

“In managing patients with heart failure, … the net benefit of multiple agents has to be weighed against the risks and the possibility of adverse events and drug interactions,” says Prof Krum.

“Patients with heart failure receive fewer life-saving drug therapies compared with those who do not have heart failure. These deficiencies in prescribing may lead to substantial increases in [cardiovascular] events in these patients.

“Given the absolute benefit of drug therapy in patients with heart failure after MI, our findings suggests the potential for suboptimal prescribing [exists] in Australian teaching hospital pracice.”
'"/>




Related medicine news :

1. College Student Commits Suicide After Failing In HSC Exams
2. "Serious Failings" Led To Spread Of Lethal Hospital Bug
3. New Device May Help Heal A Failing Heart
4. Special Exams to Help Failing Medical Students
5. Is There Any Clinical Benefit to Staying on a Failing Regimen?
6. One in Three Heart Attack Patients Have No Chest Pains
7. Epileptic Seizures Can Be Due to Heart Problem
8. Bypass Heart Surgery Performed Without General Anesthesia
9. New CPR Guidelines issued by Heart Association
10. White Cells Count Can Predict Heart Attack Death Risk
11. Vitamins-The answer to Heart Disease?
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2017)... ... March 29, 2017 , ... The Professional Squash Association, ... enlisted New York City-based sports and entertainment marketing firm Leverage Agency as its ... for the Professional Squash Association (PSA), which includes first-time ever title sponsorship, naming ...
(Date:3/29/2017)... ... ... pollen is the main cause of hay fever in the United States, with an estimated ... from May to July each year; with the worst time for sufferers being June and ... ( http://www.haymax.us ) provide an effective defense against grass pollen; they are proven in independent ...
(Date:3/29/2017)... (PRWEB) , ... March 30, 2017 , ... Youth Futures ... great success and feedback from high school and college students who have participated in ... held July 7-23 and YFI is now accepting applications for enrollment. Visit ...
(Date:3/29/2017)... (PRWEB) , ... March 30, 2017 , ... Sports Brand ... brace, which retails normally at $29.97; for the remaining days of March, the ... also been reduced to a special price of just $10 (regular retail price $19.97). ...
(Date:3/29/2017)... Louisiana (PRWEB) , ... March 29, 2017 , ... ... in three Hours at a Walgreens store in Mississippi. AngioGenesis Labs, makers of ... Walgreens Stores in two southeastern states. Ingredients in HeartBoost, an over the counter ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 2017  Glenmark Pharmaceuticals, a global pharmaceutical company, ... investigational fixed-dose combination of mometasone furoate (25 mcg) ... a nasal spray being studied for the treatment ... a recently completed Phase 3 trial assessing the ... versus mometasone, olopatadine or placebo. "We ...
(Date:3/29/2017)...  Maxor National Pharmacy Services, LLC ("Maxor"), a leading ... Leah Bailey as General Counsel.  Bailey will serve ... With more than 13 years of experience ... on health care, Bailey joins the Maxor team coming ... advised the PBM, Specialty, and Mail Order business areas ...
(Date:3/29/2017)... , March 29, 2017 Varian Medical Systems ... report results for the second quarter of fiscal year 2017 ... 2017.  The news release will be followed by a teleconference ... news release and a link to the conference call webcast ... .  To access the teleconference call and replay: ...
Breaking Medicine Technology: